proteomics

  •   George Lundberg, MD

    In order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.

    .

    .